Rilpivirine and pharmaceutically acceptable addition salts thereof including the hydrochloride salt of Rilpivirine

NO2024047I1Undetermined Publication Date: 2024-10-30JANSSEN PHARMA NV

View PDF 0 Cites 0 Cited by

Patent Information

Patent Timeline

10 Jun 2002

Priority

30 Oct 2024

Application

NO2024047C

30 Oct 2024

Publication

NO2024047I1

IPC: C07D403/12; A61K; A61K31/505; A61K31/506; A61K31/5355; A61K31/541; A61K31/551; A61K45/00; A61P31/18; C07C; C07C211/00; C07C255/42; C07C257/12; C07D; C07D233/96; C07D239/46; C07D239/47; C07D239/48; C07D401/12; C07D401/14; C07D403/14; C07D405/12; C07D407/12; C07D409/12; C07D413/12; C07D417/12

CPC: A61K31/505; A61K31/506; C07C255/42; C07C257/12; C07D239/47; C07D401/12; C07D403/12; C07D405/12

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.